Crucell, J&J deal

CRXL granted JNJ's Tibotec Pharmaceuticals Ltd. subsidiary (Mechelen, Belgium) a license to use the PER.C6 cell line for Tibotec's virology programs. CRXL will receive a license fee and annual mainten...